Navigation Links
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
Date:6/1/2008

TYKERB Demonstrates Activity in Combination with Other Targeted Therapies

and as Monotherapy Across A Range of Breast Cancer Settings - First Phase II data investigating the dual inhibition of HER2 and VEGF pathways with two oral, small molecule tyrosine-kinase inhibitors (TYKERB and pazopanib) demonstrates activity in first-line HER2 (ErbB2) positive

breast cancer(1)

- Phase II results combining TYKERB and AVASTIN(R) (bevacizumab), a monoclonal antibody, shows activity in recurrent metastatic HER2-positive

breast cancer(2)

- Final results from the largest prospective trial evaluating TYKERB monotherapy as a treatment for relapsed inflammatory breast cancer (IBC) demonstrates activity in this highly aggressive and difficult to treat

disease(3)

LONDON, and PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced the results of three studies evaluating TYKERB -- an oral, small molecule inhibitor of HER2 -- in various breast cancer settings, either in combination with other targeted therapies or as a monotherapy. Use of TYKERB in these settings is investigational. Results from these studies are being presented during the annual American Society of Clinical Oncology (ASCO) meeting in Chicago, May 30 - June 3, 2008.

Multiple cellular pathways influence the growth and metastatic potential of tumors, which is thought to be related to the ability of cancer cells to develop primary or acquired resistance.(4) It is believed that targeted inhibition of several tumor cell signaling pathways may be more effective than inhibition of a single pathway alone.(4)

"Targeted therapies, either used in combination or as a single agent, are the future of cancer treatment and may have the potential to treat patients more effectively," said Dr. Paolo Paoletti, Senior Vice President of the Oncology Medicine Developm
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
2. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
3. CVS/pharmacy Offers Flu Vaccinations in Over 4,000 Stores
4. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
5. Concentra Offers Flu Vaccines to Keep America Working
6. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
7. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
8. New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need
9. New Data Published in The Lancet Show GSKs ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
10. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
11. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... today reported financial results for the first fiscal quarter ... , Revenues of $47.5 million, up 10% over ... $0.21, up 50% over last year,s comparable quarter. ... $7.2 million, up 20% over last year,s comparable quarter. ...
(Date:7/24/2014)... 24, 2014 Amgen (NASDAQ: AMGN ) ... results on Tuesday, July 29, 2014, after the close of ... a conference call with the investment community at 2 p.m. ... Robert A. Bradway , chairman and chief executive officer, and ... audio of the conference call will be simultaneously broadcast over ...
(Date:7/24/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey ... financial results for the second quarter ended June 30, 2014. ... revenues of $6.5 million in the second quarter of 2014, ... , Total revenues of $13.3 million for the six ... the same period in 2013 , Total revenues generated ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Amgen Announces Webcast of 2014 Second Quarter Financial Results 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... SOUTH SAN FRANCISCO, Calif., Oct. 21 NGM Biopharmaceuticals, ... and development of novel biotherapeutics for the treatment of ... that Arthur D. Levinson, Ph.D., the Chairman of Genentech,s ... of Directors. Under Dr. Levinson,s leadership as Chairman ...
... PharmaNet Development Group, Inc., a leading provider of clinical ... device companies, today announced its participation at the 8th ... the World Trade Center in Rotterdam, The Netherlands from ... top management will discuss some of the most important ...
Cached Medicine Technology:NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors 2NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors 3PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam 2
(Date:7/24/2014)... (PRWEB) July 24, 2014 Memantine was initially ... first marketed in Germany under the brand name Akatinol; it ... nations as Ebixa and in the USA to Forest Labs ... 420 million in 2013. In the US, Forest reported Namenda ... protection expiry in Canada, Australia and the European region has ...
(Date:7/24/2014)... Rockville, MD (PRWEB) July 24, 2014 ... women are looking to egg freezing as a way ... potential which would otherwise decline with advancing reproductive age. ... embryos, is a cutting edge medical technology that allows ... ovaries during her peak fertility years, which are then ...
(Date:7/24/2014)... with high-throughput data generated by breast cancer biologists ... computational method to determine how gene networks are ... as they respond to potential cancer therapy agents., ... each other in laboratory-grown cells is described in ... PLOS Computational Biology . , The method ...
(Date:7/24/2014)... July 24, 2014 In a recent report ... has officially put an end to criminal penalties associated with ... new era for marijuana reform in Washington DC, giving it ... new law replaces criminal penalties for possession of one ounce ... and the possession of more than an ounce of marijuana ...
(Date:7/24/2014)... New research from Penn Medicine shows that ... length of hospital stay by 30 percent and ... when compared with conventional transfemoral TAVR, which requires ... is available in the current issue of ... replacement of the aortic valve without a traditional ...
Breaking Medicine News(10 mins):Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Penn study: Incisionless transcatheter aortic valve replacement surgery cuts hospital length of stay 2
... ,Bad, Children Can Survive - and Thrive , ... The holidays should bring peace, harmony, and treasured memories, ... difficult, even disorderly conduct among troubled children. Tantrums, defiant reactions, ... leave parents asking, "What did I do wrong?" , ...
... 18 A simple and inexpensive,developmental diagnostic assay ... to be highly accurate for rapid detection,of serious ... susceptibility. The research was reported in three ... Agents,and Chemotherapy (ICAAC). , ...
... an increasingly important part of patient consultations. , ... ... reveals physicians are accessing online clinical resources more than ever, and ... through Internet searches. Epocrates, Inc., developer of mobile and ...
... of fruit, it doesn,t seem very difficult to recognize a ... to "feature binding" a process by which our brain combines ... us a complete and unified picture of it. For example, ... to work, connecting (or binding) information about each fruit,s shape ...
... signs aren,t just for newlyweds anymore. , They are also ... sexual expression, according to Kansas State University aging experts. , ... can offer residents some privacy," said Gayle Doll, who directs ... a problem for nursing home residents who want to engage ...
... years old, close to 90 percent of children have at ... night terrors, teeth-grinding and bed-wetting. , For the majority, ... percent of children in this age group have difficulties sleeping ... slumber or they can,t stay asleep. While the effects of ...
Cached Medicine News:Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 3Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 2Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 3Health News:Epocrates Survey Identifies Trends in Online Resource Use Among Physicians 2Health News:Epocrates Survey Identifies Trends in Online Resource Use Among Physicians 3Health News:Bound by attention: Bringing rats and humans together 2Health News:K-State helps nursing home staff become comfortable with residents' sexual expression 2Health News:26 percent of sleepless children become overweight 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: